Bergman P

Safety and efficacy of the mRNA BNT162b2 vaccine against SARS-CoV-2 in five groups of immunocompromised patients and healthy controls in a prospective open-label clinical trial

Bergman P, Blennow O, Hansson L, ..., Ljungman P, Aleman S

- - (-) - [2021-09-12; online 2021-09-12]